Elanco Animal Health Inc 4

Elanco Animal Health CEO Jeffrey N. Simmons received 115.3849 deferred stock units as a routine equity compensation award.

On September 4, 2026, Elanco Animal Health Inc. President, CEO and Director Jeffrey N. Simmons received an automatic award of 115.3849 deferred stock units at an implied value of $24.50 per unit (approximately $2,825 in total), which will settle in either cash or Elanco common stock following termination of employment or in a specified future year pursuant to the company’s Executive Deferral and Stock Match Plan. These units are economically equivalent to common shares but are not immediately settled, and following this award Simmons’ indirect deferred stock unit balance increased to 25,245.5086 units (worth roughly $593,000 based on the referenced price).

Filing Facts

CIK

1739104

Ticker

ELAN

Form

4

Source Type

fda

Accession

0001479079-26-000041

Alert Tier

4